Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nadroparin”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Study completedNCT00827554
What this trial is testing

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 100
Post-approval studies (Phase 4)Study completedNCT00965328
What this trial is testing

Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration

Who this might be right for
KidneyAcute Renal FailureMultiple Organ Failure
Onze Lieve Vrouwe Gasthuis 14
Post-approval studies (Phase 4)Study completedNCT01097148
What this trial is testing

Peri -and Postoperative Drug Therapy Schedules for Morbidly Obese Patients

Who this might be right for
ObeseAtracuriumCefazolin+2 more
St. Antonius Hospital 20
Large-scale testing (Phase 3)Study completedNCT00843492
What this trial is testing

Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 1,351
Large-scale testing (Phase 3)UnknownNCT01980849
What this trial is testing

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer

Who this might be right for
Lung Cancer
Shengqing Li 272
Post-approval studies (Phase 4)UnknownNCT02295150
What this trial is testing

Prophylaxis of Venous Thromboembolism After Bariatric Surgery

Who this might be right for
Morbid ObesityThromboembolismBypass Complications
Rijnstate Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT04507178
What this trial is testing

Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine

Who this might be right for
Aneurysmal Subarachnoid HemorrhageDelayed Cerebral Ischemia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 100
Post-approval studies (Phase 4)Study completedNCT04173429
What this trial is testing

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Qilu Hospital of Shandong University 64
Large-scale testing (Phase 3)Study completedNCT01431456
What this trial is testing

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

Who this might be right for
Venous Thromboembolism
Martini Hospital Groningen 148
Not applicableUnknownNCT06319131
What this trial is testing

Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

Who this might be right for
Portal Vein Thrombosis
Shanghai Zhongshan Hospital 84
Not applicableStudy completedNCT01523652
What this trial is testing

Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

Who this might be right for
Genital Diseases, FemaleOvarian NeoplasmsUrogenital Neoplasms
Azienda Ospedaliera San Giovanni Battista 29
Post-approval studies (Phase 4)Study completedNCT00796692
What this trial is testing

Nadroparin for the Initial Treatment of Pulmonary Thromboembolism

Who this might be right for
Pulmonary EmbolismThromboembolismVascular Diseases+1 more
Beijing Chao Yang Hospital 274
Post-approval studies (Phase 4)Study completedNCT00286273
What this trial is testing

Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration

Who this might be right for
Kidney Failure, Acute
Onze Lieve Vrouwe Gasthuis 215
Post-approval studies (Phase 4)Study completedNCT04976543
What this trial is testing

Safety of Anticoagulant Therapy After Endoscopic Treatment

Who this might be right for
CirrhosisPortal Vein ThrombosisEsophageal and Gastric Varices+1 more
Qilu Hospital of Shandong University 86
Post-approval studies (Phase 4)UnknownNCT01862978
What this trial is testing

Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
University Hospital, Martin 150
Large-scale testing (Phase 3)Study completedNCT00951574
What this trial is testing

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Who this might be right for
Advanced CancerMetastatic Cancer
Italfarmaco 1,166
Large-scale testing (Phase 3)Study completedNCT00312013
What this trial is testing

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 503
Post-approval studies (Phase 4)Study completedNCT03841396
What this trial is testing

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Who this might be right for
Injection Site Reaction
Aspen Global Incorporated 15
Not applicableStudy completedNCT05621915
What this trial is testing

Nadroparin Pharmacokinetics in Different Stages of COVID-19

Who this might be right for
ThrombosisNadroparinCOVID-19+2 more
Medical University of Lublin 43
Not applicableStudy completedNCT05926518
What this trial is testing

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

Who this might be right for
Critical IllnessTherapeutic Drug MonitoringVenous Thromboembolism
Rijnstate Hospital 62